1. Home
  2. BATL vs NEPH Comparison

BATL vs NEPH Comparison

Compare BATL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Battalion Oil Corporation

BATL

Battalion Oil Corporation

HOLD

Current Price

$1.36

Market Cap

41.6M

Sector

Energy

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.38

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATL
NEPH
Founded
1987
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.6M
40.1M
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
BATL
NEPH
Price
$1.36
$3.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
4.1M
25.0K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
42.56
1000.00
EPS
N/A
0.01
Revenue
$166,043,000.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$321.00
Revenue Growth
N/A
32.67
52 Week Low
$1.00
$2.66
52 Week High
$29.70
$6.42

Technical Indicators

Market Signals
Indicator
BATL
NEPH
Relative Strength Index (RSI) 29.96 42.84
Support Level $1.05 $2.77
Resistance Level $1.51 $3.79
Average True Range (ATR) 0.15 0.19
MACD 0.08 -0.05
Stochastic Oscillator 4.44 0.00

Price Performance

Historical Comparison
BATL
NEPH

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: